Pharma & Healthcare
Global Echinocandins Antifungal Drugs Market Research Report 2023
- Jan 18, 24
- ID: 1567
- Pages: 88
- Figures: 216
- Views: 39
Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.
According to HengCe’s new survey, global Echinocandins Antifungal Drugs market is projected to reach US$ 1298.1 million in 2029, increasing from US$ 1021 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the β-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Echinocandins Antifungal Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Astellas
Endo International
Xellia Pharmaceuticals
Teva
Hikma
Apotex
Fresenius
Pfizer
CTTQ
QILU Pharmaceutical
BrightGene Bio-Medical Technology
Hansoh Pharmaceutical
Segment by Type
Caspofungin
Micafungin
Anidulafungin
Segment by Application
Hospital
Drugstore
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Echinocandins Antifungal Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to HengCe’s new survey, global Echinocandins Antifungal Drugs market is projected to reach US$ 1298.1 million in 2029, increasing from US$ 1021 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the β-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Echinocandins Antifungal Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Astellas
Endo International
Xellia Pharmaceuticals
Teva
Hikma
Apotex
Fresenius
Pfizer
CTTQ
QILU Pharmaceutical
BrightGene Bio-Medical Technology
Hansoh Pharmaceutical
Segment by Type
Caspofungin
Micafungin
Anidulafungin
Segment by Application
Hospital
Drugstore
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Echinocandins Antifungal Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 Echinocandins Antifungal Drugs Market Overview
1.1 Product Overview and Scope of Echinocandins Antifungal Drugs
1.2 Echinocandins Antifungal Drugs Segment by Type
1.2.1 Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Caspofungin
1.2.3 Micafungin
1.2.4 Anidulafungin
1.3 Echinocandins Antifungal Drugs Segment by Application
1.3.1 Global Echinocandins Antifungal Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Echinocandins Antifungal Drugs Market Size Estimates and Forecasts
1.4.1 Global Echinocandins Antifungal Drugs Revenue 2018-2029
1.4.2 Global Echinocandins Antifungal Drugs Sales 2018-2029
1.4.3 Global Echinocandins Antifungal Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Echinocandins Antifungal Drugs Market Competition by Manufacturers
2.1 Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Echinocandins Antifungal Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Echinocandins Antifungal Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Echinocandins Antifungal Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
2.7 Echinocandins Antifungal Drugs Market Competitive Situation and Trends
2.7.1 Echinocandins Antifungal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Echinocandins Antifungal Drugs Players Market Share by Revenue
2.7.3 Global Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Echinocandins Antifungal Drugs Retrospective Market Scenario by Region
3.1 Global Echinocandins Antifungal Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Echinocandins Antifungal Drugs Global Echinocandins Antifungal Drugs Sales by Region: 2018-2029
3.2.1 Global Echinocandins Antifungal Drugs Sales by Region: 2018-2023
3.2.2 Global Echinocandins Antifungal Drugs Sales by Region: 2024-2029
3.3 Global Echinocandins Antifungal Drugs Global Echinocandins Antifungal Drugs Revenue by Region: 2018-2029
3.3.1 Global Echinocandins Antifungal Drugs Revenue by Region: 2018-2023
3.3.2 Global Echinocandins Antifungal Drugs Revenue by Region: 2024-2029
3.4 North America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.4.1 North America Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.4.3 North America Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.5.1 Europe Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.5.3 Europe Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.7.1 Latin America Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.7.3 Latin America Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Echinocandins Antifungal Drugs Sales by Type (2018-2029)
4.1.1 Global Echinocandins Antifungal Drugs Sales by Type (2018-2023)
4.1.2 Global Echinocandins Antifungal Drugs Sales by Type (2024-2029)
4.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Echinocandins Antifungal Drugs Revenue by Type (2018-2029)
4.2.1 Global Echinocandins Antifungal Drugs Revenue by Type (2018-2023)
4.2.2 Global Echinocandins Antifungal Drugs Revenue by Type (2024-2029)
4.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Echinocandins Antifungal Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Echinocandins Antifungal Drugs Sales by Application (2018-2029)
5.1.1 Global Echinocandins Antifungal Drugs Sales by Application (2018-2023)
5.1.2 Global Echinocandins Antifungal Drugs Sales by Application (2024-2029)
5.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Echinocandins Antifungal Drugs Revenue by Application (2018-2029)
5.2.1 Global Echinocandins Antifungal Drugs Revenue by Application (2018-2023)
5.2.2 Global Echinocandins Antifungal Drugs Revenue by Application (2024-2029)
5.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Echinocandins Antifungal Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Echinocandins Antifungal Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Astellas Echinocandins Antifungal Drugs Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Endo International Echinocandins Antifungal Drugs Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Xellia Pharmaceuticals
6.4.1 Xellia Pharmaceuticals Corporation Information
6.4.2 Xellia Pharmaceuticals Description and Business Overview
6.4.3 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product Portfolio
6.4.5 Xellia Pharmaceuticals Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Echinocandins Antifungal Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Hikma
6.6.1 Hikma Corporation Information
6.6.2 Hikma Description and Business Overview
6.6.3 Hikma Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hikma Echinocandins Antifungal Drugs Product Portfolio
6.6.5 Hikma Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Apotex Echinocandins Antifungal Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Fresenius
6.8.1 Fresenius Corporation Information
6.8.2 Fresenius Description and Business Overview
6.8.3 Fresenius Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Fresenius Echinocandins Antifungal Drugs Product Portfolio
6.8.5 Fresenius Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Echinocandins Antifungal Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 CTTQ
6.10.1 CTTQ Corporation Information
6.10.2 CTTQ Description and Business Overview
6.10.3 CTTQ Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CTTQ Echinocandins Antifungal Drugs Product Portfolio
6.10.5 CTTQ Recent Developments/Updates
6.11 QILU Pharmaceutical
6.11.1 QILU Pharmaceutical Corporation Information
6.11.2 QILU Pharmaceutical Echinocandins Antifungal Drugs Description and Business Overview
6.11.3 QILU Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 QILU Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.11.5 QILU Pharmaceutical Recent Developments/Updates
6.12 BrightGene Bio-Medical Technology
6.12.1 BrightGene Bio-Medical Technology Corporation Information
6.12.2 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Description and Business Overview
6.12.3 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product Portfolio
6.12.5 BrightGene Bio-Medical Technology Recent Developments/Updates
6.13 Hansoh Pharmaceutical
6.13.1 Hansoh Pharmaceutical Corporation Information
6.13.2 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Description and Business Overview
6.13.3 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.13.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Echinocandins Antifungal Drugs Industry Chain Analysis
7.2 Echinocandins Antifungal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Echinocandins Antifungal Drugs Production Mode & Process
7.4 Echinocandins Antifungal Drugs Sales and Marketing
7.4.1 Echinocandins Antifungal Drugs Sales Channels
7.4.2 Echinocandins Antifungal Drugs Distributors
7.5 Echinocandins Antifungal Drugs Customers
8 Echinocandins Antifungal Drugs Market Dynamics
8.1 Echinocandins Antifungal Drugs Industry Trends
8.2 Echinocandins Antifungal Drugs Market Drivers
8.3 Echinocandins Antifungal Drugs Market Challenges
8.4 Echinocandins Antifungal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Echinocandins Antifungal Drugs
1.2 Echinocandins Antifungal Drugs Segment by Type
1.2.1 Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Caspofungin
1.2.3 Micafungin
1.2.4 Anidulafungin
1.3 Echinocandins Antifungal Drugs Segment by Application
1.3.1 Global Echinocandins Antifungal Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Echinocandins Antifungal Drugs Market Size Estimates and Forecasts
1.4.1 Global Echinocandins Antifungal Drugs Revenue 2018-2029
1.4.2 Global Echinocandins Antifungal Drugs Sales 2018-2029
1.4.3 Global Echinocandins Antifungal Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Echinocandins Antifungal Drugs Market Competition by Manufacturers
2.1 Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Echinocandins Antifungal Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Echinocandins Antifungal Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Echinocandins Antifungal Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
2.7 Echinocandins Antifungal Drugs Market Competitive Situation and Trends
2.7.1 Echinocandins Antifungal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Echinocandins Antifungal Drugs Players Market Share by Revenue
2.7.3 Global Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Echinocandins Antifungal Drugs Retrospective Market Scenario by Region
3.1 Global Echinocandins Antifungal Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Echinocandins Antifungal Drugs Global Echinocandins Antifungal Drugs Sales by Region: 2018-2029
3.2.1 Global Echinocandins Antifungal Drugs Sales by Region: 2018-2023
3.2.2 Global Echinocandins Antifungal Drugs Sales by Region: 2024-2029
3.3 Global Echinocandins Antifungal Drugs Global Echinocandins Antifungal Drugs Revenue by Region: 2018-2029
3.3.1 Global Echinocandins Antifungal Drugs Revenue by Region: 2018-2023
3.3.2 Global Echinocandins Antifungal Drugs Revenue by Region: 2024-2029
3.4 North America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.4.1 North America Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.4.3 North America Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.5.1 Europe Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.5.3 Europe Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.7.1 Latin America Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.7.3 Latin America Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Echinocandins Antifungal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Echinocandins Antifungal Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Echinocandins Antifungal Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Echinocandins Antifungal Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Echinocandins Antifungal Drugs Sales by Type (2018-2029)
4.1.1 Global Echinocandins Antifungal Drugs Sales by Type (2018-2023)
4.1.2 Global Echinocandins Antifungal Drugs Sales by Type (2024-2029)
4.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Type (2018-2029)
4.2 Global Echinocandins Antifungal Drugs Revenue by Type (2018-2029)
4.2.1 Global Echinocandins Antifungal Drugs Revenue by Type (2018-2023)
4.2.2 Global Echinocandins Antifungal Drugs Revenue by Type (2024-2029)
4.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Echinocandins Antifungal Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Echinocandins Antifungal Drugs Sales by Application (2018-2029)
5.1.1 Global Echinocandins Antifungal Drugs Sales by Application (2018-2023)
5.1.2 Global Echinocandins Antifungal Drugs Sales by Application (2024-2029)
5.1.3 Global Echinocandins Antifungal Drugs Sales Market Share by Application (2018-2029)
5.2 Global Echinocandins Antifungal Drugs Revenue by Application (2018-2029)
5.2.1 Global Echinocandins Antifungal Drugs Revenue by Application (2018-2023)
5.2.2 Global Echinocandins Antifungal Drugs Revenue by Application (2024-2029)
5.2.3 Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Echinocandins Antifungal Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Echinocandins Antifungal Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Astellas Echinocandins Antifungal Drugs Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Endo International Echinocandins Antifungal Drugs Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Xellia Pharmaceuticals
6.4.1 Xellia Pharmaceuticals Corporation Information
6.4.2 Xellia Pharmaceuticals Description and Business Overview
6.4.3 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product Portfolio
6.4.5 Xellia Pharmaceuticals Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Echinocandins Antifungal Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Hikma
6.6.1 Hikma Corporation Information
6.6.2 Hikma Description and Business Overview
6.6.3 Hikma Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hikma Echinocandins Antifungal Drugs Product Portfolio
6.6.5 Hikma Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Apotex Echinocandins Antifungal Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Fresenius
6.8.1 Fresenius Corporation Information
6.8.2 Fresenius Description and Business Overview
6.8.3 Fresenius Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Fresenius Echinocandins Antifungal Drugs Product Portfolio
6.8.5 Fresenius Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Echinocandins Antifungal Drugs Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 CTTQ
6.10.1 CTTQ Corporation Information
6.10.2 CTTQ Description and Business Overview
6.10.3 CTTQ Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CTTQ Echinocandins Antifungal Drugs Product Portfolio
6.10.5 CTTQ Recent Developments/Updates
6.11 QILU Pharmaceutical
6.11.1 QILU Pharmaceutical Corporation Information
6.11.2 QILU Pharmaceutical Echinocandins Antifungal Drugs Description and Business Overview
6.11.3 QILU Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 QILU Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.11.5 QILU Pharmaceutical Recent Developments/Updates
6.12 BrightGene Bio-Medical Technology
6.12.1 BrightGene Bio-Medical Technology Corporation Information
6.12.2 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Description and Business Overview
6.12.3 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product Portfolio
6.12.5 BrightGene Bio-Medical Technology Recent Developments/Updates
6.13 Hansoh Pharmaceutical
6.13.1 Hansoh Pharmaceutical Corporation Information
6.13.2 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Description and Business Overview
6.13.3 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product Portfolio
6.13.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Echinocandins Antifungal Drugs Industry Chain Analysis
7.2 Echinocandins Antifungal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Echinocandins Antifungal Drugs Production Mode & Process
7.4 Echinocandins Antifungal Drugs Sales and Marketing
7.4.1 Echinocandins Antifungal Drugs Sales Channels
7.4.2 Echinocandins Antifungal Drugs Distributors
7.5 Echinocandins Antifungal Drugs Customers
8 Echinocandins Antifungal Drugs Market Dynamics
8.1 Echinocandins Antifungal Drugs Industry Trends
8.2 Echinocandins Antifungal Drugs Market Drivers
8.3 Echinocandins Antifungal Drugs Market Challenges
8.4 Echinocandins Antifungal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Echinocandins Antifungal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Echinocandins Antifungal Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Echinocandins Antifungal Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Echinocandins Antifungal Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Echinocandins Antifungal Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Echinocandins Antifungal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Echinocandins Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Echinocandins Antifungal Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Echinocandins Antifungal Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Echinocandins Antifungal Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Echinocandins Antifungal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Echinocandins Antifungal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Echinocandins Antifungal Drugs Product
Table 74. Merck Recent Developments/Updates
Table 75. Astellas Corporation Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Astellas Echinocandins Antifungal Drugs Product
Table 79. Astellas Recent Developments/Updates
Table 80. Endo International Corporation Information
Table 81. Endo International Description and Business Overview
Table 82. Endo International Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Endo International Echinocandins Antifungal Drugs Product
Table 84. Endo International Recent Developments/Updates
Table 85. Xellia Pharmaceuticals Corporation Information
Table 86. Xellia Pharmaceuticals Description and Business Overview
Table 87. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product
Table 89. Xellia Pharmaceuticals Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Echinocandins Antifungal Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Hikma Corporation Information
Table 96. Hikma Description and Business Overview
Table 97. Hikma Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hikma Echinocandins Antifungal Drugs Product
Table 99. Hikma Recent Developments/Updates
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Apotex Echinocandins Antifungal Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Fresenius Corporation Information
Table 106. Fresenius Description and Business Overview
Table 107. Fresenius Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Fresenius Echinocandins Antifungal Drugs Product
Table 109. Fresenius Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Pfizer Echinocandins Antifungal Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. CTTQ Corporation Information
Table 116. CTTQ Description and Business Overview
Table 117. CTTQ Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. CTTQ Echinocandins Antifungal Drugs Product
Table 119. CTTQ Recent Developments/Updates
Table 120. QILU Pharmaceutical Corporation Information
Table 121. QILU Pharmaceutical Description and Business Overview
Table 122. QILU Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. QILU Pharmaceutical Echinocandins Antifungal Drugs Product
Table 124. QILU Pharmaceutical Recent Developments/Updates
Table 125. BrightGene Bio-Medical Technology Corporation Information
Table 126. BrightGene Bio-Medical Technology Description and Business Overview
Table 127. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product
Table 129. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 130. Hansoh Pharmaceutical Corporation Information
Table 131. Hansoh Pharmaceutical Description and Business Overview
Table 132. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product
Table 134. Hansoh Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Echinocandins Antifungal Drugs Distributors List
Table 138. Echinocandins Antifungal Drugs Customers List
Table 139. Echinocandins Antifungal Drugs Market Trends
Table 140. Echinocandins Antifungal Drugs Market Drivers
Table 141. Echinocandins Antifungal Drugs Market Challenges
Table 142. Echinocandins Antifungal Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Echinocandins Antifungal Drugs
Figure 2. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Echinocandins Antifungal Drugs Market Share by Type in 2022 & 2029
Figure 4. Caspofungin Product Picture
Figure 5. Micafungin Product Picture
Figure 6. Anidulafungin Product Picture
Figure 7. Global Echinocandins Antifungal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Echinocandins Antifungal Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Drugstore
Figure 11. Global Echinocandins Antifungal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Echinocandins Antifungal Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Echinocandins Antifungal Drugs Sales (2018-2029) & (K Units)
Figure 14. Global Echinocandins Antifungal Drugs Average Price (US$/Unit) & (2018-2029)
Figure 15. Echinocandins Antifungal Drugs Report Years Considered
Figure 16. Echinocandins Antifungal Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Echinocandins Antifungal Drugs Players: Market Share by Revenue in 2022
Figure 19. Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 23. United States Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Echinocandins Antifungal Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Echinocandins Antifungal Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 42. Latin America Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Echinocandins Antifungal Drugs by Type (2018-2029)
Figure 52. Global Revenue Market Share of Echinocandins Antifungal Drugs by Type (2018-2029)
Figure 53. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Echinocandins Antifungal Drugs by Application (2018-2029)
Figure 55. Global Revenue Market Share of Echinocandins Antifungal Drugs by Application (2018-2029)
Figure 56. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2018-2029)
Figure 57. Echinocandins Antifungal Drugs Value Chain
Figure 58. Echinocandins Antifungal Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Echinocandins Antifungal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Echinocandins Antifungal Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Echinocandins Antifungal Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Echinocandins Antifungal Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Echinocandins Antifungal Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Echinocandins Antifungal Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Echinocandins Antifungal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Echinocandins Antifungal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Echinocandins Antifungal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Echinocandins Antifungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Echinocandins Antifungal Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Echinocandins Antifungal Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Echinocandins Antifungal Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Echinocandins Antifungal Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Echinocandins Antifungal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Echinocandins Antifungal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Echinocandins Antifungal Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Echinocandins Antifungal Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Echinocandins Antifungal Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Echinocandins Antifungal Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Echinocandins Antifungal Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Echinocandins Antifungal Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Echinocandins Antifungal Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Echinocandins Antifungal Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Echinocandins Antifungal Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Echinocandins Antifungal Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Echinocandins Antifungal Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Echinocandins Antifungal Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Echinocandins Antifungal Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Echinocandins Antifungal Drugs Product
Table 74. Merck Recent Developments/Updates
Table 75. Astellas Corporation Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Astellas Echinocandins Antifungal Drugs Product
Table 79. Astellas Recent Developments/Updates
Table 80. Endo International Corporation Information
Table 81. Endo International Description and Business Overview
Table 82. Endo International Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Endo International Echinocandins Antifungal Drugs Product
Table 84. Endo International Recent Developments/Updates
Table 85. Xellia Pharmaceuticals Corporation Information
Table 86. Xellia Pharmaceuticals Description and Business Overview
Table 87. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Xellia Pharmaceuticals Echinocandins Antifungal Drugs Product
Table 89. Xellia Pharmaceuticals Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Echinocandins Antifungal Drugs Product
Table 94. Teva Recent Developments/Updates
Table 95. Hikma Corporation Information
Table 96. Hikma Description and Business Overview
Table 97. Hikma Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hikma Echinocandins Antifungal Drugs Product
Table 99. Hikma Recent Developments/Updates
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Apotex Echinocandins Antifungal Drugs Product
Table 104. Apotex Recent Developments/Updates
Table 105. Fresenius Corporation Information
Table 106. Fresenius Description and Business Overview
Table 107. Fresenius Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Fresenius Echinocandins Antifungal Drugs Product
Table 109. Fresenius Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Pfizer Echinocandins Antifungal Drugs Product
Table 114. Pfizer Recent Developments/Updates
Table 115. CTTQ Corporation Information
Table 116. CTTQ Description and Business Overview
Table 117. CTTQ Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. CTTQ Echinocandins Antifungal Drugs Product
Table 119. CTTQ Recent Developments/Updates
Table 120. QILU Pharmaceutical Corporation Information
Table 121. QILU Pharmaceutical Description and Business Overview
Table 122. QILU Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. QILU Pharmaceutical Echinocandins Antifungal Drugs Product
Table 124. QILU Pharmaceutical Recent Developments/Updates
Table 125. BrightGene Bio-Medical Technology Corporation Information
Table 126. BrightGene Bio-Medical Technology Description and Business Overview
Table 127. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. BrightGene Bio-Medical Technology Echinocandins Antifungal Drugs Product
Table 129. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 130. Hansoh Pharmaceutical Corporation Information
Table 131. Hansoh Pharmaceutical Description and Business Overview
Table 132. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Hansoh Pharmaceutical Echinocandins Antifungal Drugs Product
Table 134. Hansoh Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Echinocandins Antifungal Drugs Distributors List
Table 138. Echinocandins Antifungal Drugs Customers List
Table 139. Echinocandins Antifungal Drugs Market Trends
Table 140. Echinocandins Antifungal Drugs Market Drivers
Table 141. Echinocandins Antifungal Drugs Market Challenges
Table 142. Echinocandins Antifungal Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Echinocandins Antifungal Drugs
Figure 2. Global Echinocandins Antifungal Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Echinocandins Antifungal Drugs Market Share by Type in 2022 & 2029
Figure 4. Caspofungin Product Picture
Figure 5. Micafungin Product Picture
Figure 6. Anidulafungin Product Picture
Figure 7. Global Echinocandins Antifungal Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Echinocandins Antifungal Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Drugstore
Figure 11. Global Echinocandins Antifungal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Echinocandins Antifungal Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Echinocandins Antifungal Drugs Sales (2018-2029) & (K Units)
Figure 14. Global Echinocandins Antifungal Drugs Average Price (US$/Unit) & (2018-2029)
Figure 15. Echinocandins Antifungal Drugs Report Years Considered
Figure 16. Echinocandins Antifungal Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Echinocandins Antifungal Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Echinocandins Antifungal Drugs Players: Market Share by Revenue in 2022
Figure 19. Echinocandins Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Echinocandins Antifungal Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 23. United States Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Echinocandins Antifungal Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Echinocandins Antifungal Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 42. Latin America Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Echinocandins Antifungal Drugs Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Echinocandins Antifungal Drugs Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Echinocandins Antifungal Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Echinocandins Antifungal Drugs by Type (2018-2029)
Figure 52. Global Revenue Market Share of Echinocandins Antifungal Drugs by Type (2018-2029)
Figure 53. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Echinocandins Antifungal Drugs by Application (2018-2029)
Figure 55. Global Revenue Market Share of Echinocandins Antifungal Drugs by Application (2018-2029)
Figure 56. Global Echinocandins Antifungal Drugs Price (US$/Unit) by Application (2018-2029)
Figure 57. Echinocandins Antifungal Drugs Value Chain
Figure 58. Echinocandins Antifungal Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232